3rd Quarter - Amendment

MEHLMAN CONSULTING, INC. for MAYO CLINIC

Firm
Client
Income
$30,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
3rd Quarter - Report Oct 20, 2022 $30,000 Replaced
3rd Quarter - Amendment (this page) May 9, 2023 $30,000 Yes

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

General healthcare; health reform; healthcare value and quality; health information technology; clinical trials; tele-health; healthcare costs; healthcare interoperability. Promoting biomedical research. Clinical laboratory capacity and reimbursement issues. Financial support for providers for diagnosis and treatment related to COVID-19, coverage of COVID-19 related conditions, access to PPE and other materials and equipment related to the treatment of patients with COVID-19. Issues related to COVID vaccine distribution. Telehealth Public Health Emergency. S. 4348 - The FDA Safety & Landmark Advancements Act (FDASLA) laboratory provisions. Inflation Reduction Act (H.R. 5376) Public Law No. 117-169. H.R. 6833 - Continuing Resolution.

Contacted: Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 6833 (117th), S. 4348 (117th), H.R. 5376 (117th)

Medicare/Medicaid MMM

General healthcare; health reform; healthcare value and quality; health information technology; clinical trials; tele-health; healthcare costs; healthcare interoperability. Promoting biomedical research. Rural health. Clinical laboratory capacity and reimbursement issues. Financial support for providers for diagnosis and treatment related to COVID-19, coverage of COVID-19 related conditions, access to PPE and other materials and equipment related to the treatment of patients with COVID-19. Telehealth. Medicare physician payment; Impact of statutory pay-go on health care providers; Delay of Protecting Access to Medicare Act (PAMA) laboratory reimbursement reporting requirements. H.R. 7053/S. 3792 - Hospital Inpatient Services Modernization Act. Public Health Emergency. H.R. 4058/S. 2061 - Tele-mental Health Access to Care Act. Inflation Reduction Act (H.R. 5376) Public Law No. 117-169. H.R. 6833 - Continuing Resolution.

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE

Bills named: H.R. 6833 (117th), H.R. 4058 (117th), S. 2061 (117th), S. 3792 (117th), H.R. 7053 (117th), H.R. 5376 (117th)

Copyright/Patent/Trademark CPT

Monitoring issues related to patent reform.

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.